Translate this page into:
Letter to the Editor
doi:
10.4103/sajc.sajc_17_18
Neoadjuvant chemotherapy in locally advanced invasive lobular carcinoma: A limited institutional experience
1
Department of Medical Oncology, All Institute of Medical Sciences, New Delhi
2
Department of Medical Oncology, FMRI, Gurgaon, Haryana
3
Department of Surgical Oncology, All Institute of Medical Sciences, New Delhi
4
Department of Pathology, All Institute of Medical Sciences, New Delhi
5
Department of Radiation, All Institute of Medical Sciences, New Delhi
*Corresponding author: Dr. Ajay Gogia. ajaygogia@gmail.com
MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Disclaimer:
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
References
- Barroso-Sousa R, Metzger-Filho O. Differences between invasive lobular and invasive ductal carcinoma of the breast: Results and therapeutic implications. Ther Adv Med Oncol 2016;8:261-6.
- Gogia A, Raina V, Deo SV, Shukla NK, Mohanti BK, Sharma DN, et al. Taxane and anthracycline based neoadjuvant chemotherapy for locally advanced breast cancer: Institutional experience. Asian Pac J Cancer Prev 2014;15:1989-92.
- Tsung K, Grobmyer SR, Tu C, Abraham J, Budd GT, Valente SA, et al. Neoadjuvant systemic therapy in invasive lobular breast cancer: Is it indicated? Am J Surg 2017. pii: S0002-9610 (17) 30998-4.
- Karen Tsung B, Stephen R, Grobmyer A, Chao Tu A, Jame Abraham C, Thomas G, et al. Stephanie pathologic predictors of treatment response to neo-adjuvant chemotherapy for invasive lobular breast carcinoma. Breast J 2017;23:607-9.
- Truin W, Vugts G, Roumen RM, Maaskant-Braat AJ, Nieuwenhuijzen GA, van der Heiden-van der Loo M, et al. Differences in response and surgical management with neoadjuvant chemotherapy in invasive lobular versus ductal breast cancer. Ann Surg Oncol 2016;23:51-7.